Scientists at the University of British Columbia and Janssen LLC have shown for the first time that Type 2 diabetes can be effectively treated with a combination of specially-cultured stem cells and conventional diabetes drugs. The opensource study published in Stem Cell Reports, holds a much broader potential because Type 2 diabetes accounts for more than 90 per cent of diabetes cases.
Type 2 diabetes usually arises in adulthood, often stemming from poor diet, lack of exercise and obesity. Unlike Type 1 diabetes, in which insulin production is largely absent, Type 2 diabetes results from the body’s cells reduced ability to respond to insulin. As a result, sugar (glucose) accumulates to toxic levels in the blood. Almost 400 million people worldwide have diabetes, and it’s the eighth leading cause of death. It is more common in developed countries and has exploded in frequency during the past few decades due mostly to decreased activity levels and worsening diets. From 1999 to 2009, the prevalence of diagnosed diabetes among Canadians increased by 70 per cent.
The team state that the cheapest, simplest way to treat type 2 diabetes is through diet and exercise, but this alone is not always effective. Several orally-administered drugs enhance insulin production or improve the body’s sensitivity to insulin, but can lose their effectiveness over time and carry various side-effects. Many patients are put on a regimen of self-injected insulin, but dosing can be difficult to calibrate, and it can promote weight gain.
In the current study the team simulated Type 2 diabetes in mice by putting them on a high-fat, high-calorie diet for several weeks. The researchers then surgically implanted pancreatic-like cells that had been grown in the laboratory from human stem cells.
The data showed that the mice that received a combination of the cells with one of three diabetes drugs became as ‘glucose tolerant’ as the healthy mice, meaning they were able to keep their blood sugar in check even after ingesting a sugary meal. In contrast, a group of mice with simulated Type 2 diabetes that received the drugs but not the transplants remained glucose-intolerant.
The team explain that being able to reduce spikes in blood sugar levels is important because evidence suggests it’s those spikes that do a lot of the damage, increasing risks for blindness, heart attack, and kidney failure. The combination therapy also caused the mice to return to a normal weight, the same weight as a healthy control group that had been reared on a low-fat diet. Their weight loss was intriguing, because some of the common diabetes therapies often lead to weight gain with the team adding that they need to do more studies to understand how the cell transplants lead to weight loss.
The researchers are also investigating if higher doses of the cells, beyond the five million tested in this study, can achieve the same results without the need for additional drugs.
Source: University of British Columbia
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.